Germline mutations in FH confer predisposition to malignant pheochromocytomas and paragangliomasLuis Jaime Castro‐Vega, Anne‐Paule Gimenez‐Roqueplo, Alexandre Buffet et al.|Human Molecular Genetics|2013Cited by 394
Ketoconazole in Cushing's Disease: Is It Worth a Try?Frédéric Castinetti, Thierry Brue, Delphine Vezzosi et al.|The Journal of Clinical Endocrinology & Metabolism|2014Cited by 288
Prognostic factors in stage III–IV adrenocortical carcinomas (ACC): an European Network for the Study of Adrenal Tumor (ENSAT) studyRossella Libé, Éric Baudin, Isabelle Borget et al.|Annals of Oncology|2015Cited by 257
Temozolomide treatment can improve overall survival in aggressive pituitary tumors and pituitary carcinomasHélène Lasolle, Gérald Raverot, Christine Cortet et al.|European Journal of Endocrinology|2017Cited by 142
Positive Impact of Genetic Test on the Management and Outcome of Patients With Paraganglioma and/or PheochromocytomaAlexandre Buffet, Laurène Ben Aim, Sophie Leboulleux et al.|The Journal of Clinical Endocrinology & Metabolism|2019Cited by 124